There is a realistic expectation that the global effort in vaccination will bring the pandemic
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) under control …

Influenza viruses cause annual epidemics and occasional pandemics of respiratory tract
infections that produce a wide spectrum of clinical disease severity in humans. The novel …

Influenza viruses replicate within the nucleus of the host cell. This uncommon RNA virus trait
provides influenza with the advantage of access to the nuclear machinery during replication …

Vaccine confidence depends on trust in vaccines as products and trust in the system that
produces them. In the US, this system consists of a complex network connecting …

Recently, the World Health Organization confirmed 120 new human cases of avian H7N9
influenza in China resulting in 37 deaths, highlighting the concern for a potential pandemic …

Lower and upper respiratory infections are the fourth highest cause of global mortality.
Epidemic and pandemic outbreaks of respiratory infection are a major medical concern …

In the current century, the development of medicine and molecular biotechnology led to
successful containment and even eradication of some human pathogens, especially in …

The broad-spectrum antiviral drug Arbidol shows efficacy against influenza viruses by
targeting the hemagglutinin (HA) fusion machinery. However, the structural basis of the …

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody
neutralization response and its evasion by emerging viral variants and variant of concern …

Influenza A viruses (IAVs) possess a great zoonotic potential as they are able to infect
different avian and mammalian animal hosts, from which they can be transmitted to humans …